Spots Global Cancer Trial Database for amg 386
Every month we try and update this database with for amg 386 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | NCT01493505 | Fallopian Tube ... Ovarian Cancer Peritoneal Canc... | AMG 386 Paclitaxel AMG 386 Placebo Carboplatin | 18 Years - | Amgen | |
| TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer | NCT01493505 | Fallopian Tube ... Ovarian Cancer Peritoneal Canc... | AMG 386 Paclitaxel AMG 386 Placebo Carboplatin | 18 Years - | Amgen | |
| Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer | NCT01666977 | Non Small Cell ... | AMG 386 AMG 386 AMG 386 Placebo Pemetrexed Carboplatin | 18 Years - 95 Years | Amgen | |
| Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma | NCT01907308 | Urothelial Carc... | AMG 386 Docetaxel | 18 Years - | University of Colorado, Denver | |
| TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer | NCT01204749 | Fallopian Tube ... Ovarian Cancer Primary Periton... | AMG 386 AMG 386 Placebo Paclitaxel Paclitaxel | 18 Years - | Amgen | |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma | NCT00752570 | Cancer Carcinoma Colon Cancer Colorectal Canc... Gastrointestina... Metastases Metastatic Canc... Metastatic Colo... Oncology Rectal Cancer | AMG 386 AMG 386 Placebo FOLFIRI | 18 Years - | Amgen | |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. | NCT00861419 | Advanced Solid ... | Sorafenib AMG 706 AMG 706 AMG 386 Sunitinib Bevacizumab AMG 386 | 18 Years - | Amgen | |
| AMG 386 Drug-Drug Interaction Study With Paclitaxel | NCT01992341 | Advanced Solid ... | AMG 386 Paclitaxel | 18 Years - | Amgen | |
| AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib | NCT00467025 | Advanced Renal ... | AMG 386 Sorafenib AMG 386 placebo... | 18 Years - | Amgen | |
| Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors | NCT00102830 | Tumors | AMG 386 | 18 Years - | Amgen | |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma | NCT00752570 | Cancer Carcinoma Colon Cancer Colorectal Canc... Gastrointestina... Metastases Metastatic Canc... Metastatic Colo... Oncology Rectal Cancer | AMG 386 AMG 386 Placebo FOLFIRI | 18 Years - | Amgen | |
| AMG 386 and Abiraterone for Advanced Prostate Cancer | NCT01553188 | Prostatic Neopl... Prostate Cancer Neoplasm, Prost... Neoplasm,Prosta... | AMG 386 Abiraterone Prednisone | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib. | NCT00861419 | Advanced Solid ... | Sorafenib AMG 706 AMG 706 AMG 386 Sunitinib Bevacizumab AMG 386 | 18 Years - | Amgen | |
| A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma | NCT00752570 | Cancer Carcinoma Colon Cancer Colorectal Canc... Gastrointestina... Metastases Metastatic Canc... Metastatic Colo... Oncology Rectal Cancer | AMG 386 AMG 386 Placebo FOLFIRI | 18 Years - | Amgen | |
| Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer | NCT01253681 | Carcinoma Fallopian Tube ... Ovarian Cancer Primary Periton... | AMG 386, paclit... | 18 Years - | Amgen | |
| Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer | NCT01253681 | Carcinoma Fallopian Tube ... Ovarian Cancer Primary Periton... | AMG 386, paclit... | 18 Years - | Amgen | |
| AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib | NCT00467025 | Advanced Renal ... | AMG 386 Sorafenib AMG 386 placebo... | 18 Years - | Amgen | |
| Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients | NCT00511459 | Locally Recurre... | AMG 386 Placebo AMG 386 Bevacizumab AMG 386 AMG 386 Paclitaxel | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
